AQST Q1 2022 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$431M

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$12M+10.3% YoY

Gross Profit

$8M65.7% margin

Operating Income

-$10M-79.4% margin

Net Income

-$13M-107.7% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+10.8%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$913,000

Balance Sheet

Total Assets

$57M

Total Liabilities

$150M

Stockholders' Equity

-$93M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$11M	+10.3%
Gross Profit	$8M	$8M	-3.7%
Operating Income	-$10M	-$9M	-14.2%
Net Income	-$13M	-$15M	+9.9%

Revenue Segments

Manufacture and Supply Revenue

$9M75%

Proprietary Product Sales

$2M18%

License and Royalty Revenue

$506,0004%

Co-Development and Research Fees

$403,0003%

Geographic Segments

UNITED STATES

$11M90%

Non-US

$1M10%